These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 8384124
1. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. Chedeville A, Mirossay L, Chastre E, Hurbain-Kosmath I, Lopez M, Gespach C. FEBS Lett; 1993 Mar 15; 319(1-2):171-6. PubMed ID: 8384124 [Abstract] [Full Text] [Related]
2. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H. Endocrinology; 1997 May 15; 138(5):1930-4. PubMed ID: 9112389 [Abstract] [Full Text] [Related]
3. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L. Endocrinology; 1995 May 15; 136(5):2088-98. PubMed ID: 7720658 [Abstract] [Full Text] [Related]
13. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms. Xiao D, Chu MM, Lee EK, Lin HR, Wong AO. Neuroendocrinology; 2002 Nov 15; 76(5):325-38. PubMed ID: 12457043 [Abstract] [Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide- and VIP-induced activation of adenylate cyclase in the porcine non-pigmented ciliary epithelium: effects of antagonists. Samuelsson-Almén M, Nilsson SF. J Ocul Pharmacol Ther; 1999 Oct 15; 15(5):389-400. PubMed ID: 10530700 [Abstract] [Full Text] [Related]
15. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP. Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M. Ann N Y Acad Sci; 2000 Oct 15; 921():92-102. PubMed ID: 11193883 [Abstract] [Full Text] [Related]
16. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. Endocrinology; 1999 Mar 15; 140(3):1285-93. PubMed ID: 10067855 [Abstract] [Full Text] [Related]
18. Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides. Absood A, Chen D, Håkanson R. Regul Pept; 1992 Aug 13; 40(3):311-22. PubMed ID: 1332141 [Abstract] [Full Text] [Related]
20. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation. Jóźwiak-Bębenista M, Kowalczyk E, Nowak JZ. Pharmacol Rep; 2015 Apr 13; 67(2):332-8. PubMed ID: 25712659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]